Susan Bonner-Weir

Title: Susan Bonner-Weir: Innovator in Diabetes Research

Introduction

Susan Bonner-Weir is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of diabetes research, particularly in the development of methods and compositions that enhance pancreatic function. With a total of 2 patents, her work focuses on promoting the maturity of insulin-secreting cells and improving treatments for diabetes.

Latest Patents

Susan Bonner-Weir's latest patents include innovative approaches to diabetes treatment. The first patent, titled "Compositions and methods for promoting beta cell maturity," outlines methods for providing an enriched population of mature, glucose-responsive insulin-secreting cells. This invention aims to modulate insulin expression, activity, and secretion in subjects. The second patent, "Methods of making pancreatic islet cells," features techniques for promoting the dedifferentiation of pancreatic cells. It also describes methods for obtaining pancreatic islet cells from these dedifferentiated cells, which can be used to treat disorders characterized by insufficient pancreatic islet function.

Career Highlights

Susan Bonner-Weir is affiliated with the Joslin Diabetes Center, Inc., where she continues her research and development efforts. Her work has been instrumental in advancing our understanding of pancreatic function and diabetes treatment.

Collaborations

Some of her notable coworkers include Monica Taneja and Cristina Aguayo-Mazzucato, who contribute to the collaborative research environment at the Joslin Diabetes Center.

Conclusion

Susan Bonner-Weir's innovative work in diabetes research has led to significant advancements in the field. Her patents reflect her commitment to improving the lives of those affected by diabetes through scientific innovation.